In Friday’s Wall Street session, Castle Biosciences Inc (NASDAQ:CSTL) shares traded at $27.32, down -1.05% from the previous session.
CSTL stock price is now -2.80% away from the 50-day moving average and 1.47% away from the 200-day moving average. The market capitalization of the company currently stands at $765.23M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $25, Guggenheim recently initiated with Buy rating for Castle Biosciences Inc (NASDAQ: CSTL). On January 05, 2023, Scotiabank recently initiated its ‘Sector Outperform’ rating on the stock quoting a target price of $54, while ‘Stephens’ rates the stock as ‘Overweight’
In other news, BRADBURY DANIEL, Director sold 7,867 shares of the company’s stock on Feb 05 ’25. The stock was sold for $221,637 at an average price of $28.17. Upon completion of the transaction, the Director now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 05 ’25, Officer Daniel Bradbury bought 7,867 shares of the business’s stock. A total of $221,220 was incurred on buying the stock at an average price of $28.12. A total of 3.09% of the company’s stock is owned by insiders.
During the past 12 months, Castle Biosciences Inc has had a low of $16.97 and a high of $35.84. As of last week, the company has a debt-to-equity ratio of 0.06, a current ratio of 7.78, and a quick ratio of 7.64. According to the stock market information, the enterprise value for the company is $512114464, which is based on a 136.67 price-to-earnings ratio, a 10.09 price-to-earnings-growth ratio, and a beta of 0.94. The fifty day moving average price for CSTL is $28.1076 and a two-hundred day moving average price translates $26.923426 for the stock.
The latest earnings results from Castle Biosciences Inc (NASDAQ: CSTL) was released for 2024-09-30. The net profit margin was 1.95% and return on equity was 1.47% for CSTL. The company reported revenue of $85.78 million for the quarter, compared to $61.49 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 39.5 percent.
